Share-based Payment Arrangement, Expense of BIOLIFE SOLUTIONS INC from 30 Sep 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIOLIFE SOLUTIONS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 30 Sep 2011 to 30 Sep 2025.
  • BIOLIFE SOLUTIONS INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $5,895,000, a 43% increase year-over-year.
  • BIOLIFE SOLUTIONS INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $20,178,000, a 40% increase year-over-year.
  • BIOLIFE SOLUTIONS INC annual Share-based Payment Arrangement, Expense for 2024 was $16,514,000, a 29% decline from 2023.
  • BIOLIFE SOLUTIONS INC annual Share-based Payment Arrangement, Expense for 2023 was $23,249,000, a 31% increase from 2022.
  • BIOLIFE SOLUTIONS INC annual Share-based Payment Arrangement, Expense for 2022 was $17,726,000, a 27% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIOLIFE SOLUTIONS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $20,178,000 $5,895,000 +$1,761,000 +43% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $18,417,000 $5,849,000 +$1,878,000 +47% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $16,539,000 $4,153,000 +$25,000 +0.61% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $16,514,000 $4,281,000 +$2,111,000 +97% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
Q3 2024 $14,403,000 $4,134,000 -$3,850,000 -48% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $18,253,000 $3,971,000 -$1,761,000 -31% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $20,014,000 $4,128,000 -$3,235,000 -44% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $23,249,000 $2,170,000 +$2,115,000 +3845% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $21,134,000 $7,984,000 +$1,685,000 +27% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 $19,449,000 $5,732,000 -$241,000 -4% 01 Apr 2023 30 Jun 2023 10-Q 09 Aug 2024 2024 Q2
Q1 2023 $19,690,000 $7,363,000 +$1,964,000 +36% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q4 2022 $17,726,000 $55,000 -$3,993,000 -99% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $21,719,000 $6,299,000 +$1,431,000 +29% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $20,288,000 $5,973,000 +$3,453,000 +137% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $16,835,000 $5,399,000 +$2,879,000 +114% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $13,956,000 $4,048,000 +$1,885,000 +87% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $12,071,000 $4,868,000 +$3,308,000 +212% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $8,763,000 $2,520,000 +$1,375,000 +120% 01 Apr 2021 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $7,388,000 $2,520,000 +$1,407,000 +126% 01 Jan 2021 31 Mar 2021 10-Q 09 Aug 2022 2022 Q2
Q4 2020 $5,981,000 $2,163,000 +$1,298,000 +150% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2023 2022 FY
Q3 2020 $4,683,000 $1,560,000 +$731,000 +88% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $3,952,000 $1,145,000 +$327,000 +40% 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021 2021 Q2
Q1 2020 $3,625,000 $1,113,000 +$582,000 +110% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q4 2019 $3,043,000 $865,000 +$476,000 +122% 01 Oct 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
Q3 2019 $2,567,000 $829,000 +$446,000 +116% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $2,121,000 $818,000 +$444,000 +119% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020 2020 Q2
Q1 2019 $1,677,000 $531,000 +$158,000 +42% 01 Jan 2019 31 Mar 2019 10-Q 29 May 2020 2020 Q1
Q4 2018 $1,519,000 $389,000 +$76,711 +25% 01 Oct 2018 31 Dec 2018 10-K 15 May 2020 2019 FY
Q3 2018 $1,442,289 $383,000 +$69,057 +22% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $1,373,232 $374,000 +$60,127 +19% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019 2019 Q2
Q1 2018 $1,313,105 $373,000 +$43,105 +13% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $1,270,000 $312,289 +$119,141 +62% 01 Oct 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q3 2017 $1,150,859 $313,943 +$132,859 +73% 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018 2018 Q3
Q2 2017 $1,018,000 $313,873 +$57,638 +22% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $960,362 $329,895 +$183,368 +125% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018 2018 Q1
Q4 2016 $776,994 $193,148 01 Oct 2016 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q3 2016 $181,084 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 $256,235 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017 2017 Q2
Q1 2016 $146,527 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017 2017 Q1
Q3 2012 $57,134 +$5,346 +10% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2012 2012 Q3
Q3 2011 $51,788 01 Jul 2011 30 Sep 2011 10-Q 13 Nov 2012 2012 Q3

BIOLIFE SOLUTIONS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $16,514,000 -$6,735,000 -29% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025 2024 FY
2023 $23,249,000 +$5,523,000 +31% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025 2024 FY
2022 $17,726,000 +$3,770,000 +27% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025 2024 FY
2021 $13,956,000 +$7,975,000 +133% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $5,981,000 +$2,938,000 +97% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2023 2022 FY
2019 $3,043,000 +$1,524,000 +100% 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2022 2021 FY
2018 $1,519,000 +$249,000 +20% 01 Jan 2018 31 Dec 2018 10-K 15 May 2020 2019 FY
2017 $1,270,000 +$493,006 +63% 01 Jan 2017 31 Dec 2017 10-K 15 Mar 2019 2018 FY
2016 $776,994 +$265,537 +52% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2018 2017 FY
2015 $511,457 01 Jan 2015 31 Dec 2015 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.